Clinical pathways for oncological gastrectomy: Are they a suitable instrument for process standardization to improve process and outcome quality of patients undergoing gastrectomy? - A retrospective cohort study
- Conditions
- Clinical pathway in oncological gastric surgery
- Registration Number
- DRKS00020323
- Lead Sponsor
- niversitätsmedizin Mannheim - Chirurgische Klinik
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 126
Inclusion Criteria
All patients undergoing elective oncological gastrectomy were included. The intervention group (CP group) comprised all consecutive patients operated following the implementation of the CP in October 2012. The control group (pre-CP group) comprised all patients operated in the two years before CP implementation, respectively.
Exclusion Criteria
No exclusion criteria
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Treatment and outcome quality for patients undergoing oncological gastrectomy. <br><br>Process quality was assessed among others by the following parameters:<br>- day of drain or catheter removal<br>- day of mobilization<br>- day of intake of fluids and solids after surgery<br><br>Outcome quality was assessed among others by the following parameters: <br>- day of discharge<br>- request of analgetics
- Secondary Outcome Measures
Name Time Method Morbidity (hospital stay and readmission until day 14 after discharge) by assessing postoperative complications (reoperation rate, anastomotic leakage, duodenal stump insufficiency, bleeding, postoperative pancreatic fistulas) according to the Clavien-Dindo classification); mortality (in-hospital mortality)